Missing out on the biology of heterosexual HIV-1 transmission

Trends in Microbiology

Volumn 21, Issue 5, 2013, Pages 245-252

  Southern, Peter J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Heterosexual HIV 1 transmission; Human reproduction; Human based studies; Semen

Indexed keywords

AMYLOID; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; INTERLEUKIN 6; INTERLEUKIN 8; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; ZINC ION;

ACROSOME REACTION; FERTILIZATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SEMINAL PLASMA; SEXUAL TRANSMISSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; TRANSCRIPTION REGULATION; UNPROTECTED SEX; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX MUCUS; VAGINA FLORA; VIRION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS RELEASE; VIRUS TRANSMISSION;

FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; SEXUAL BEHAVIOR;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84877139873     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.02.002     Document Type: Review

References (83)

1. Coombs R.W., et al. Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS 2003, 17:455-480.
2. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
3. Cohen M.S., et al. Acute HIV-1 infection. N. Engl. J. Med. 2011, 364:1943-1954.
4. Powers K.A., et al. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:553-563.
5. De Jonge C. Biological basis for human capacitation. Hum. Reprod. Update 2005, 11:205-214.
6. Suarez S.S., Pacey A.A. Sperm transport in the female reproductive tract. Hum. Reprod. Update 2006, 12:23-37.
7. Gipson I.K., et al. The amount of MUC5B mucin in cervical mucus peaks at midcycle. J. Clin. Endocrinol. Metab. 2001, 86:594-600.
8. Feki N.C., et al. Human sperm lipid content is modified after migration into human cervical mucus. Mol. Hum. Reprod. 2004, 10:137-142.
9. Riley-Vargas R.C., et al. Targeted and restricted complement activation on acrosome-reacted spermatozoa. J. Clin. Invest. 2005, 115:1241-1249.
10. Settlage D.S., et al. Sperm transport from the external cervical os to the fallopian tubes in women: a time and quantitation study. Fertil. Steril. 1973, 24:655-661.
11. Wilcox A.J., et al. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N. Engl. J. Med. 1995, 333:1517-1521.
12. Jacobson D.L., et al. Histologic development of cervical ectopy: relationship to reproductive hormones. Sex. Transm. Dis. 2000, 27:252-258.
13. Wira C.R., Fahey J.V. A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008, 22:1909-1917.
14. Kay V.J., Robertson L. Hyperactivated motility of human spermatozoa: a review of physiological function and application in assisted reproduction. Hum. Reprod. Update 1998, 4:776-786.
15. Brewis I.A., Gadella B.M. Sperm surface proteomics: from protein lists to biological function. Mol. Hum. Reprod. 2010, 16:68-79.
16. World Health Organization WHO Laboratory Manual for the Examination and Processing of Human Semen 2010, World Health Organization.
17. Bezold G., et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil. Steril. 2007, 87:1087-1097.
18. Owen D.H., Katz D.F. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J. Androl. 2005, 26:459-469.
19. Rodriguez-Martinez H., et al. Seminal plasma proteins: what role do they play?. Am. J. Reprod. Immunol. 2011, 66(Suppl. 1):11-22.
20. Rolland A.D., et al. Identification of genital tract markers in the human seminal plasma using an integrative genomics approach. Hum. Reprod. 2013, 28:199-209.
21. Coombs R.W., et al. Lower genitourinary tract sources of seminal HIV. J. Acquir. Immune Defic. Syndr. 2006, 41:430-438.
22. Anderson D.J., et al. Targeting Trojan Horse leukocytes for HIV prevention. AIDS 2010, 24:163-187.
23. Dejucq N., Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol. Mol. Biol. Rev. 2001, 65:208-231.
24. Ceballos A., et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J. Exp. Med. 2009, 206:2717-2733.
25. Maher D., et al. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11504-11509.
26. Blaskewicz C.D., et al. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol. Reprod. 2011, 85:97-104.
27. Fiore J.R., et al. The use of serum-free medium delays, but does not prevent, the cytotoxic effects of seminal plasma in lymphocyte cultures: implications for studies on HIV infection. New Microbiol. 1997, 20:339-344.
28. Prakash M., et al. Recruitment of CD4 T lymphocytes and macrophages into the cervical epithelium of women after coitus. Am. J. Obstet. Gynecol. 2003, 188:376-381.
29. Thompson L.A., et al. The leukocytic reaction of the human uterine cervix. Am. J. Reprod. Immunol. 1992, 28:85-89.
30. Alghamdi A.S., Foster D.N. Seminal DNase frees spermatozoa entangled in neutrophil extracellular traps. Biol. Reprod. 2005, 73:1174-1181.
31. Politch J.A., et al. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 2007, 22:2928-2935.
32. Lusk M.J., Konecny P. Cervicitis: a review. Curr. Opin. Infect. Dis. 2008, 21:49-55.
33. Horbul J.E., et al. Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 in human cervical organ culture. PLoS ONE 2011, 6:e22638.
34. Sharkey D.J., et al. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J. Immunol. 2012, 188:2445-2454.
35. Miller C.J., et al. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 1992, 21:64-68.
36. Hladik F., McElrath M.J. Setting the stage: host invasion by HIV. Nat. Rev. Immunol. 2008, 8:447-457.
37. Li Q., et al. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009, 323:1726-1729.
38. Sommers M.S. Defining patterns of genital injury from sexual assault: a review. Trauma Violence Abuse 2007, 8:270-280.
39. Zink T., et al. Comparison of methods for identifying ano-genital injury after consensual intercourse. J. Emerg. Med. 2010, 39:113-118.
40. Neofytou E., et al. Prevalence of human herpes virus types 1-7 in the semen of men attending an infertility clinic and correlation with semen parameters. Fertil. Steril. 2009, 91:2487-2494.
41. Lai S.K., et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J. Virol. 2009, 83:11196-11200.
42. Shukair S.A., et al. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol. 2013, 6:427-434.
43. Balkus J.E., et al. Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women. BMC Infect. Dis. 2012, 12:188.
44. Fredricks D.N., et al. Molecular identification of bacteria associated with bacterial vaginosis. N. Engl. J. Med. 2005, 353:1899-1911.
45. Brosnahan A.J., et al. Cytolysins augment superantigen penetration of stratified mucosa. J. Immunol. 2009, 182:2364-2373.
46. Myer L., et al. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect. Dis. 2005, 5:786-794.
47. Schwandt M., et al. Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex. Transm. Infect. 2006, 82:392-396.
48. Baeten J.M., et al. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin. Infect. Dis. 2007, 45:360-369.
49. Heffron R., et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect. Dis. 2012, 12:19-26.
50. Marx P.A., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 1996, 2:1084-1089.
51. Hel Z., et al. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocr. Rev. 2010, 31:79-97.
52. Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat. Rev. Immunol. 2010, 10:699-711.
53. Southern P.J., et al. Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems. Mucosal Immunol. 2011, 4:383-396.
54. Keele B.F. Identifying and characterizing recently transmitted viruses. Curr. Opin. HIV AIDS 2010, 5:327-334.
55. Miller C.J., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 2005, 79:9217-9227.
56. Anderson J.A., et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 2010, 6:e10011053.
57. Lisco A., et al. HIV-1 imposes rigidity on blood and semen cytokine networks. Am. J. Reprod. Immunol. 2012, 68:515-521.
58. Narimatsu R., et al. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res. Hum. Retroviruses 2005, 21:228-233.
59. Sharkey D.J., et al. TGF-beta mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. J. Immunol. 2012, 189:1024-1035.
60. Ingman W.V., Robertson S.A. The essential roles of TGFβ1 in reproduction. Cytokine Growth Factor Rev. 2009, 20:233-239.
61. Estes J.D., et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 2006, 193:703-712.
62. Doncel G.F., et al. Role of semen in HIV-1 transmission: inhibitor or facilitator?. Am. J. Reprod. Immunol. 2011, 65:292-301.
63. Cole A.M. Innate host defense of human vaginal and cervical mucosae. Curr. Top. Microbiol. Immunol. 2006, 306:199-230.
64. Munch J., et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071.
65. Kim K.A., et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010, 7:55.
66. Roan N.R., et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 2011, 10:541-550.
67. Sabatte J., et al. The role of semen in sexual transmission of HIV: beyond a carrier for virus particles. Microbes Infect. 2011, 13:977-982.
68. Denton P.W., Garcia J.V. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice. Trends Microbiol. 2012, 20:268-274.
69. Kumar S.B., et al. Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge. Retrovirology 2010, 7:49.
70. Hatziioannou T., Evans D.T. Animal models for HIV/AIDS research. Nat. Rev. Microbiol. 2012, 10:852-867.
71. Harris C.L., et al. Complement and complement regulators in the male reproductive system. Mol. Immunol. 2006, 43:57-67.
72. Tjomsland V., et al. Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS ONE 2011, 6:e23542.
73. Bouhlal H., et al. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J. Immunol. 2002, 169:3301-3306.
74. Cummerson J.A., et al. The complement regulatory proteins CD55 (decay accelerating factor) and CD59 are expressed on the inner acrosomal membrane of human spermatozoa as well as CD46 (membrane cofactor protein). Immunology 2006, 118:333-342.
75. Emami N., et al. Major role of human KLK14 in seminal clot liquefaction. J. Biol. Chem. 2008, 283:19561-19569.
76. Kim C.H., et al. Zinc-induced NF-κB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol. Appl. Pharmacol. 2003, 190:189-196.
77. + ions in host-virus interactions. J. Virol. 2008, 82:11486-11494.
78. Rana U., et al. Zinc binding ligands and cellular zinc trafficking: apo-metallothionein, glutathione, TPEN, proteomic zinc, and Zn-Sp1. J. Inorg. Biochem. 2008, 102:489-499.
79. Robertson S.A. Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res. 2005, 322:43-52.
80. Remes Lenicov F., et al. Semen promotes the differentiation of tolerogenic dendritic cells. J. Immunol. 2012, 189:4777-4786.
81. Mestecky J., et al. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J. Reprod. Immunol. 2009, 83:196-200.
82. Lefevre P.L., et al. Polyamines on the reproductive landscape. Endocr. Rev. 2011, 32:694-712.
83. Pegg A.E., Casero R.A. Current status of the polyamine research field. Methods Mol. Biol. 2011, 720:3-35.